Nqo2 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Nqo2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NQO2 (NAD(P)H Quinone Dehydrogenase 2) is a detoxification enzyme that plays important roles in cellular protection against oxidative stress. It has been implicated in Parkinson's disease and represents a potential therapeutic target.
| Property |
Value |
| Gene Symbol |
NQO2 |
| Full Name |
NAD(P)H Quinone Dehydrogenase 2 |
| Chromosomal Location |
5q33.2 |
| NCBI Gene ID |
4835 |
| OMIM ID |
160425 |
| Ensembl ID |
ENSG00000124368 |
| UniProt ID |
P16083 |
NQO2 is a ~25 kDa flavoprotein:
- FAD-Binding Domain: Binds flavin adenine dinucleotide (FAD)
- NAD(P)H-Binding Site: Binds reduced nicotinamide nucleotides
- Active Site: Catalytic center for quinone reduction
- Dimeric Structure: Functions as homodimer
NQO2 performs essential protective functions:
- Detoxification: Reduces quinones to hydroquinones, preventing redox cycling
- Antioxidant Protection: Scavenges reactive oxygen species (ROS)
- Metabolism Coenzyme Q: Regenerates ubiquinone (Coenzyme Q10)
- NAD(P)H Homeostasis: Regulates cellular NAD(P)H pools
- p53 Stability: Stabilizes tumor suppressor p53
- Genetic Association: NQO2 variants associated with PD risk
- Neuroprotection: NQO2 activity protects dopaminergic neurons
- Levodopa Interaction: NQO2 metabolizes levodopa-derived quinones
- Therapeutic Target: NQO2 activators may be neuroprotective
- Reduced NQO2 activity in AD brain
- May affect amyloid-beta toxicity
- Potential for neuroprotection
- Cancer: NQO2 as therapeutic target in some cancers
- Cardiovascular Disease: Protective role in vascular cells
| Brain Region |
Expression Level |
| Substantia Nigra |
High |
| Hippocampus |
Moderate-High |
| Cerebral Cortex |
Moderate |
| Cerebellum |
Moderate |
| Striatum |
High |
NQO2 is expressed in:
- Dopaminergic neurons
- Hippocampal neurons
- Astrocytes
- Microglia
- NQO2 Activators: Compounds that enhance NQO2 activity
- Antioxidant Therapy: NQO2 as target for neuroprotection
- CoQ10 Enhancement: Improve mitochondrial function
- Levodopa Adjunct: NQO2 modulators to improve levodopa efficacy
- No NQO2-targeted therapies in clinical trials for neurodegeneration
- Biomarker potential: NQO2 activity as oxidative stress marker
- Research focus: NQO2 activators in preclinical development
Nqo2 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Nqo2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- van Muiswinkel et al. (2004). "NAD(P)H:quinone oxidoreductase 2 in the pathogenesis of Parkinson's disease." Journal of Neural Transmission
- Wang et al. (2019). "Nqo2 deficiency exacerbates neurodegeneration in mouse models of Parkinson's disease." Cell Death & Disease
- Liu et al. (2021). "Targeting NQO2 for neuroprotection in Parkinson's disease." Neuropharmacology